JP2022551583A5 - - Google Patents
Info
- Publication number
- JP2022551583A5 JP2022551583A5 JP2022520290A JP2022520290A JP2022551583A5 JP 2022551583 A5 JP2022551583 A5 JP 2022551583A5 JP 2022520290 A JP2022520290 A JP 2022520290A JP 2022520290 A JP2022520290 A JP 2022520290A JP 2022551583 A5 JP2022551583 A5 JP 2022551583A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- chemical formula
- pharmaceutical composition
- following chemical
- acceptable complex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962909006P | 2019-10-01 | 2019-10-01 | |
| US62/909,006 | 2019-10-01 | ||
| PCT/US2020/053369 WO2021067335A1 (en) | 2019-10-01 | 2020-09-30 | Benzoxazinone compounds as klk5/7 dual inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022551583A JP2022551583A (ja) | 2022-12-12 |
| JP2022551583A5 true JP2022551583A5 (https=) | 2023-09-29 |
| JP7854389B2 JP7854389B2 (ja) | 2026-05-01 |
Family
ID=75274622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022520290A Active JP7854389B2 (ja) | 2019-10-01 | 2020-09-30 | Ｋｌｋ５／７デュアル阻害剤としてのベンゾキサジノン化合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11643420B2 (https=) |
| EP (1) | EP4037687B1 (https=) |
| JP (1) | JP7854389B2 (https=) |
| KR (1) | KR20220091488A (https=) |
| CN (1) | CN114615984B (https=) |
| AU (1) | AU2020359526A1 (https=) |
| BR (1) | BR112022005881A2 (https=) |
| CA (1) | CA3151626A1 (https=) |
| ES (1) | ES3053975T3 (https=) |
| IL (1) | IL291398B2 (https=) |
| MX (1) | MX2022003929A (https=) |
| WO (1) | WO2021067335A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20200040103A1 (en) | 2018-03-14 | 2020-02-06 | Genentech, Inc. | Anti-klk5 antibodies and methods of use |
| PH12022550646A1 (en) | 2019-09-18 | 2023-04-03 | Genentech Inc | Anti-klk7 antibodies, anti-klk5 antibodies, multispecific anti-klk5/klk7 antibodies, and methods of use |
| ES3053975T3 (en) | 2019-10-01 | 2026-01-28 | Molecular Skin Therapeutics Inc | Benzoxazinone compounds as klk5/7 dual inhibitors |
| TW202304890A (zh) * | 2021-04-14 | 2023-02-01 | 美商百歐克斯製藥公司 | Klk5雙環雜芳香族抑制劑 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
| US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
| HU196714B (en) | 1984-10-04 | 1989-01-30 | Monsanto Co | Process for producing non-aqueous composition comprising somatotropin |
| IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
| CA1309556C (en) * | 1987-06-09 | 1992-10-27 | Masayuki Kokubo | 4h-3,1-benzoxazin-4-one compounds and pharmaceutical composition thereoffor the inhibition of serine proteases |
| US5073543A (en) | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
| IT1229203B (it) | 1989-03-22 | 1991-07-25 | Bioresearch Spa | Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative. |
| PH30995A (en) | 1989-07-07 | 1997-12-23 | Novartis Inc | Sustained release formulations of water soluble peptides. |
| US5120548A (en) | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
| US5733566A (en) | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
| DE4134770A1 (de) | 1991-10-22 | 1993-04-29 | Basf Ag | Koernige bleichaktivatorzusammensetzung |
| US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
| TW333456B (en) | 1992-12-07 | 1998-06-11 | Takeda Pharm Ind Co Ltd | A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide. |
| US5591767A (en) | 1993-01-25 | 1997-01-07 | Pharmetrix Corporation | Liquid reservoir transdermal patch for the administration of ketorolac |
| US6087324A (en) | 1993-06-24 | 2000-07-11 | Takeda Chemical Industries, Ltd. | Sustained-release preparation |
| IT1270594B (it) | 1994-07-07 | 1997-05-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida |
| AU6242096A (en) | 1995-06-27 | 1997-01-30 | Takeda Chemical Industries Ltd. | Method of producing sustained-release preparation |
| TW448055B (en) | 1995-09-04 | 2001-08-01 | Takeda Chemical Industries Ltd | Method of production of sustained-release preparation |
| JP2909418B2 (ja) | 1995-09-18 | 1999-06-23 | 株式会社資生堂 | 薬物の遅延放出型マイクロスフイア |
| US5980945A (en) | 1996-01-16 | 1999-11-09 | Societe De Conseils De Recherches Et D'applications Scientifique S.A. | Sustained release drug formulations |
| US6264970B1 (en) | 1996-06-26 | 2001-07-24 | Takeda Chemical Industries, Ltd. | Sustained-release preparation |
| US6419961B1 (en) | 1996-08-29 | 2002-07-16 | Takeda Chemical Industries, Ltd. | Sustained release microcapsules of a bioactive substance and a biodegradable polymer |
| CA2184851A1 (en) | 1996-09-05 | 1998-03-06 | Cheng Chung Wu | Method of manufacturing a microweavable flatware article made of synthetic material, the article produced thereby and an ink-imprinted film component for use in making the flatware article |
| CA2217134A1 (en) | 1996-10-09 | 1998-04-09 | Sumitomo Pharmaceuticals Co., Ltd. | Sustained release formulation |
| PT839525E (pt) | 1996-10-31 | 2004-10-29 | Takeda Chemical Industries Ltd | Preparacao de libertacao prolongada |
| WO1998027980A2 (en) | 1996-12-20 | 1998-07-02 | Takeda Chemical Industries, Ltd. | Method of producing a sustained-release preparation |
| US5891474A (en) | 1997-01-29 | 1999-04-06 | Poli Industria Chimica, S.P.A. | Time-specific controlled release dosage formulations and method of preparing same |
| US6613358B2 (en) | 1998-03-18 | 2003-09-02 | Theodore W. Randolph | Sustained-release composition including amorphous polymer |
| PL343317A1 (en) * | 1998-03-31 | 2001-08-13 | Warner Lambert Co | Benzoxazinones/benzothiazinones as serine protease inhibitors |
| KR19990085365A (ko) | 1998-05-16 | 1999-12-06 | 허영섭 | 지속적으로 약물 조절방출이 가능한 생분해성 고분자 미립구 및그 제조방법 |
| US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| SI1631295T1 (sl) | 2003-06-06 | 2010-06-30 | Arexis Ab | Uporaba kondenziranih heterocikličnih spojin kotSCCE inhibitorjev za zdravljenje kožnih bolezni |
| SI3097085T1 (sl) | 2014-01-23 | 2020-11-30 | Sixera Pharma Ab | Derivati benzoksazinona za zdravljenje kožnih bolezni |
| ES3053975T3 (en) | 2019-10-01 | 2026-01-28 | Molecular Skin Therapeutics Inc | Benzoxazinone compounds as klk5/7 dual inhibitors |
-
2020
- 2020-09-30 ES ES20872712T patent/ES3053975T3/es active Active
- 2020-09-30 JP JP2022520290A patent/JP7854389B2/ja active Active
- 2020-09-30 WO PCT/US2020/053369 patent/WO2021067335A1/en not_active Ceased
- 2020-09-30 CN CN202080069819.7A patent/CN114615984B/zh active Active
- 2020-09-30 US US17/037,910 patent/US11643420B2/en active Active
- 2020-09-30 KR KR1020227014268A patent/KR20220091488A/ko active Pending
- 2020-09-30 EP EP20872712.3A patent/EP4037687B1/en active Active
- 2020-09-30 CA CA3151626A patent/CA3151626A1/en active Pending
- 2020-09-30 AU AU2020359526A patent/AU2020359526A1/en active Pending
- 2020-09-30 BR BR112022005881A patent/BR112022005881A2/pt unknown
- 2020-09-30 IL IL291398A patent/IL291398B2/en unknown
- 2020-09-30 MX MX2022003929A patent/MX2022003929A/es unknown
-
2023
- 2023-04-03 US US18/295,009 patent/US12281123B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022551583A5 (https=) | ||
| JP7745892B2 (ja) | Ｎ４－ヒドロキシシチジンおよび誘導体ならびにそれらに関連する抗ウイルス用途 | |
| RU2606947C2 (ru) | Борсодержащие малые молекулы | |
| JP5389668B2 (ja) | 皮膚浸透率の非常に高い１Ｈ−イミダゾ［４，５−ｃ］キノリン−４−アミン及び関連化合物の正に荷電した水溶性プロドラッグ | |
| RU2325389C2 (ru) | Композиция и производные замещенного азаиндолоксоацетапиперазина, обладающие противовирусной активностью | |
| JPS62230722A (ja) | 肥満および／または関連状態の治療剤 | |
| WO1997044034A1 (en) | Remedy for rosacea | |
| RU2005135016A (ru) | Производные хинолина в качестве ингибиторов фосфодиэстеразы | |
| CN116157387A (zh) | 异喹啉化合物及其在治疗AhR失衡中的用途 | |
| CN108601760A (zh) | 艾日布林的合成中的中间体及相关的合成方法 | |
| BR0015117A (pt) | Composto, composição farmacêutica, métodos para tratar um paciente quanto a dor, quanto a doença de parkinson, quanto ao câncer, quanto a aids, processos para preparar um composto, para preparar (1s, 2s) -n- (1-hidróxi-1,2-diidro-naftalen-2-il)- benzeno sulfonamida, e para preparar o éster dimetìlico do áciso (1s*,2r*) -2- (hidróxi -1,2- diidro - naftalen -2- il ) malÈnico | |
| CN103483158B (zh) | 一种二苯乙烷衍生物及其应用 | |
| RU2004102398A (ru) | Производные бензо[g]хинолина для лечения глаукомы и близорукости | |
| CA2435611A1 (en) | Alpha-amino-n-hydroxy-acetamide derivatives | |
| US20180085345A1 (en) | Methods of tracking skin conditions using cyclolignan compounds | |
| EP4119165A1 (en) | Novel 3,5-diaminobenzoic acid compound, and pin1 inhibitor and therapeutic agent for inflammatory diseases using same | |
| JP2024509993A (ja) | セレコキシブのプロドラッグ及びその調製方法並びに適用 | |
| IT1307786B1 (it) | Analoghi di ceramidi, processo per la loro preparazione e loro usocome antitumorali. | |
| WO2020143744A1 (en) | New formulations containing leukotriene receptor antagonists | |
| RU2005115102A (ru) | Новые противоопухолевые соединения | |
| JP2021504470A (ja) | Ｎ−アセチル又はｎ−アシルアミノ酸を含むアトピー又は痒み症治療用組成物 | |
| CN110709087A (zh) | 皮肤问题抑制剂及皮肤问题抑制用组合物 | |
| FR2470110A1 (fr) | Derives de la decrapenylamine, leurs sels acides d'addition et composition pharmaceutique renfermant ces produits | |
| JPH10175852A5 (https=) | ||
| CN117088862B (zh) | 一种硫代色元酮衍生物和应用 |